RE: RE: RE: Endo presentation ??How do you guys see epitopix as a competitor to Econiche?
Do you think the FDA might delay the approval for Econiche in order to give time for Epitopix to catch up?
Even though Epitopix is a late comer, it has Pfizer as partner, providing the industries clouts in development, marketing and sales force. Also being a U.S. product, will it get preferred over Econiche? The fact that there are already orders from a few of the major meat suppliers in U.S. lined up even though Epitopix only has a conditional license and Econiche failed to achieve that at the same stage makes me a bit worried about Econiche's sale potential in the U.S.
Can you guys shed some light on this?